bonefos 800 mg film-coat. tabl.
bayer sa-nv - disodium clodronate tetrahydrate - eq. clodronate disodium 800 mg - film-coated tablet - 800 mg - clodronate disodium 800 mg - clodronic acid
clasteon 800 mg
bioavenir ltd, israel - clodronic acid as disodium tetrathydrate - film coated tablets - clodronic acid as disodium tetrathydrate 800 mg - clodronic acid - treatment of hypercalcemia due to malignancy. palliative treatment of osteolysis due to malignancy.
bonefos ® 800 mg
bayer israel ltd - clodronic acid disodium 800 mg - film coated tablets - clodronic acid - treatment of hypercalcemia due to malignancy. palliative treatment of osteolysis due to malignancy.
ostac
roche products (nz) ltd - disodium clodronate 520mg (649.73mg clodronic acid disodium salt tetrahydrate) - film coated tablet - 520 mg - active: disodium clodronate 520mg (649.73mg clodronic acid disodium salt tetrahydrate) excipient: hypromellose lactose monohydrate macrogol 10000 magnesium stearate maize starch methacrylic acid copolymer polysorbate 80 purified talc sodium citrate dihydrate sodium starch glycolate titanium dioxide
osphos 51 mg/ml solution for injection for horses
dechra limited - clodronic acid (equivalent to clodronate disodium tetrahydrate ph. eur.) - solution for injection - 51 mg/ml - clodronic acid - equine - food - miscellaneous
osphos 51 mg/ml solution for injection for horses
dechra ltd - clodronic acid as disodium clodronate - parenteral liquid/solution/suspension - clodronic acid as disodium clodronate bisphosphonate active 51.0 mg/ml - musculoskeletal system
osphos 51 mg/ml solution for injection for horses
dechra ltd - clodronic acid - solution for injection - 51 milligram(s)/millilitre - clodronic acid - horses - miscellaneous
osphos- clodronate disodium injection, solution
dechra veterinary products - clodronate disodium (unii: n030400h8j) (clodronic acid - unii:0813bz6866) - clodronate disodium 60 mg in 1 ml - indication: for the control of clinical signs associated with navicular syndrome in horses. contraindications: horses with hypersensitivity to clodronate disodium should not receive osphos. do not use in horses with impaired renal function or with a history of renal disease.
osphos 51 mg/ml solution for injection for horses
dechra regulatory b.v. - clodronate disodium tetrahydrate - solution for injection - 51 milligram(s)/millilitre - clodronic acid
osphos 51 mg/ml solution for injection for horses
dechra limited - clodronic acid - solution for injection - musculoskeletal - horses